Why choose Herts?

Teaching Excellence: You will be taught by Internationally renowned researchers who support with research projects in Cancer Immunotherapy.

Employment Prospects: Graduates work as research scientists, scientific officers, and senior managers for organisations including Roche, Merck, and Astra Zeneca.

Sector-led Course Content: Explore our research interests of the Bioscience Research Group covering topics such as Adoptive T cell therapy, tumour-associated macrophages, NK cells, and monoclonal antibodies in cancer therapy.

 

About the course

The aim of the MSc in Cancer Immunotherapy is through an understanding of the numerous ways in which cancers and the immune system interact, to learn how cancer immunotherapies are developed. The utilisation of the immune system in cancer therapy has been a long standing goal in the field. The course will provide a thorough understanding of immune effector mechanisms and of cancer biology and the personal skills the students will develop, through problem-based learning and self-directed learning.